Marcyrl Pharmaceutical Industries
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Marcyrl Pharmaceutical Industries - overview
Established
1998
Location
Cairo, -, Egypt
Primary Industry
Pharmaceuticals
About
Based in Cairo, Egypt, and founded in 1998, Marcyrl Pharmaceutical Industries operates as an import and export and manufacturing company that functions in the pharmaceutical industry. In April 2023, Development Partners International and Amethis invested in Marcyrl Pharmaceutical Industries. As of 2023, the company is led by managing director Farid Habib. The firm manufacture, import, and export various pharmaceutical products which include medicines and equipment for surgeries and other medical processes.
It offers medical tablets, ointments, creams, solutions, and capsules for various diseases and body improvements such as cardiology, chest, hematology, tonics, pediatrics, etc. The company plans to use the April 2023 funding to accelerate its growth and explore new opportunities to deliver cost-effective, critical solutions to healthcare practitioners and their patients across Egypt and Sub-Saharan Africa.
Current Investors
Development Partners International, Amethis
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.marcyrl.com
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Marcyrl Pharmaceutical Industries - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Marcyrl Pharmaceutical Industries | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.